Professur für Experimentelle Biomedizin

Differential Levels and Phosphorylation of Type 1 Inositol 1,4,5-Trisphosphate Receptor in Four Different Murine Models of Huntington Disease (2019) Post JI, Leergaard TB, Ratz V, Walaas SI, von Hörsten S, Nissen-Meyer LSH Journal article Role of hypothalamus-pituitary-adrenal axis modulation in the stress-resilient phenotype of DPP4-deficient rats (2019) Golub Y, Schildbach EM, Touma C, Kratz O, Moll G, von Hörsten S, Canneva F Journal article Systematic Data Analysis and Data Mining in Gait Analysis by Heat Mapping (2018) Timotius I, Canneva F, Minakaki G, Moceri S, Casadei N, Riess O, Winkler J, et al. Conference contribution, Conference Contribution Rodent’s Stride Length Depends on Body Size: Implications for CatWalk Assay (2018) Timotius I, Moceri S, Plank AC, Habermeyer J, Canneva F, Casadei N, Riess O, et al. Conference contribution, Conference Contribution Dynamic footprints of α-synucleinopathic mice recorded by CatWalk gait analysis (2018) Timotius I, Canneva F, Minakaki G, Pasluosta CF, Moceri S, Casadei N, Riess O, et al. Journal article Association of early phenotypic behavioral alterations in human alpha-synuclein overexpressing transgenic rats with alpha-synuclein/huntingtin/amyloid-beta protein cross-seeding (2018) Moceri S, Canneva F, Habermeyer J, Dobner J, Schulze-Krebs A, Puchades M, Bjaalie JG, et al. Conference contribution, Abstract of a poster Dynamic footprint based locomotion sway assessment in α-synucleinopathic mice using Fast Fourier Transform and Low Pass Filter (2018) Timotius I, Canneva F, Minakaki G, Pasluosta CF, Moceri S, Casadei N, Riess O, et al. Journal article, Original article NORMALIZATION OF PHENOTYPE AND REDUCTION OF GLIOSIS LEVELS VIA GLUTAMINYL CYCLASES INHIBITION IN A HUNTINGTON DISEASE MOUSE MODEL (2018) Plank AC, Schilling S, Hoffmann T, Lues I, von Hörsten S Conference contribution Early Alterations in Operant Performance and Prominent Huntingtin Aggregation in a Congenic F344 Rat Line of the Classical CAGn51truncModel of Huntington Disease (2018) Plank AC, Canneva F, Raber KA, Urbach YK, Dobner J, Puchades M, Bjaalie JG, et al. Journal article Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition (2018) Siebzehnrubl FA, Reber KA, Urbach YK, Schulze-Krebs A, Canneva F, Moceri S, Habermeyer J, et al. Journal article